BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxorubicin
,
rs7903146
,
MYC
,
calcium channel activity
,
Pseudomonas infection
,
Embryo
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
prostate specific membrane antigen
Summary
General Info
Curated Studies
Most Correlated Studies
Human body index - transcriptional profiling
L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Change in total lesion PSMA (TLP) during [177Lu]Lu-PSMA-617 radioligand therapy predicts overall sur…
Semiautomatic assessment of whole-body tumor burden with 18F-PSMA-1007 in biochemical recurrent pros…
Physiological 68Ga-PSMA-11 Uptake in Dural Venous Sinuses.
Assessing dynamic metabolic heterogeneity in prostate cancer patients via total-body [68Ga]Ga-PSMA-1…
A prospective study of 68Ga-PSMA PET/CT imaging of HCC as diagnosed on conventional imaging to evalu…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression
Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer
A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Prostate-S…
The Application Value of 18F-prostate-specific Membrane Antigen PET/CT in Prostate Cancer
Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Loc…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ